Goldman Sachs Healthcare Stocks: Top 10 Stock Picks

5. Boston Scientific Corporation (NYSE:BSX)

Goldman Sachs Equity Stake: $1.41 Billion

Number of Hedge Fund Holders: 108

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 price target following FDA approval to expand the use of its Farapulse system for treating persistent atrial fibrillation (AFib).

Previously approved for paroxysmal AFib, the system showed strong safety and efficacy results in clinical trials, with no strokes and over 85% of patients free from arrhythmia recurrence after one year.

The company sees significant growth potential in persistent AFib, which accounts for 25–50% of cases and anticipates further regulatory approvals in Europe, Japan, and China. Boston Scientific is also advancing new clinical research with the ReMatch trial, highlighting its continued innovation in cardiac care solutions.

Boston Scientific Corporation (NYSE:BSX) is a medical technology company that develops, manufactures, and markets medical devices. Its products are used in various interventional medical specialties to improve patient outcomes and address unmet needs.